HEADER TRANSCRIPTION 08-JUL-22 7YFK TITLE THE STRUCTURE OF HUMAN PREGNANE X RECEPTOR IN COMPLEX WITH AN SRC-1 TITLE 2 COACTIVATOR PEPTIDE AND A LIMONOID COMPOUND, NOMILIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2,NUCLEAR COMPND 3 RECEPTOR COACTIVATOR 1; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: ORPHAN NUCLEAR RECEPTOR PAR1,ORPHAN NUCLEAR RECEPTOR PXR, COMPND 6 PREGNANE X RECEPTOR,STEROID AND XENOBIOTIC RECEPTOR,SXR,NCOA-1,CLASS COMPND 7 E BASIC HELIX-LOOP-HELIX PROTEIN 74,BHLHE74,PROTEIN HIN-2,RIP160, COMPND 8 RENAL CARCINOMA ANTIGEN NY-REN-52,STEROID RECEPTOR COACTIVATOR 1,SRC- COMPND 9 1; COMPND 10 EC: 2.3.1.48; COMPND 11 ENGINEERED: YES; COMPND 12 OTHER_DETAILS: 2-306; PREGNANE X RECEPTOR, 307-321:LINKER, 313- COMPND 13 337:SRC-1, 338-340: TAG,2-306; PREGNANE X RECEPTOR, 307-321:LINKER, COMPND 14 313-337:SRC-1, 338-340: TAG SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2, PXR, NCOA1, BHLHE74, SRC1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS COMPLEX, ACTIVATOR, TRANSCRIPTION, DRUG BINDING, NUCLEAR RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR Y.XIA,D.YAO,C.HUANG,Y.CAO REVDAT 3 29-NOV-23 7YFK 1 REMARK REVDAT 2 21-JUN-23 7YFK 1 JRNL REVDAT 1 14-JUN-23 7YFK 0 SPRSDE 14-JUN-23 7YFK 7CHG JRNL AUTH S.FAN,Y.YAN,Y.XIA,Z.ZHOU,L.LUO,M.ZHU,Y.HAN,D.YAO,L.ZHANG, JRNL AUTH 2 M.FANG,L.PENG,J.YU,Y.LIU,X.GAO,H.GUAN,H.LI,C.WANG,X.WU, JRNL AUTH 3 H.ZHU,Y.CAO,C.HUANG JRNL TITL PREGNANE X RECEPTOR AGONIST NOMILIN EXTENDS LIFESPAN AND JRNL TITL 2 HEALTHSPAN IN PRECLINICAL MODELS THROUGH DETOXIFICATION JRNL TITL 3 FUNCTIONS. JRNL REF NAT COMMUN V. 14 3368 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 37291126 JRNL DOI 10.1038/S41467-023-39118-9 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.30 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 47751 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.89 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7YFK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-JUL-22. REMARK 100 THE DEPOSITION ID IS D_1300030816. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9789 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48171 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 37.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.05394 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.6800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 5X0R REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% (V/V) 2-PROPANOL, 100 MM REMARK 280 IMIDAZOLE/ HYDROCHLORIC ACID, PH 8.0, EVAPORATION, TEMPERATURE REMARK 280 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.49300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.19550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.08150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.19550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.49300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.08150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 VAL A 140 REMARK 465 GLN A 141 REMARK 465 LEU A 178 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 THR A 311 REMARK 465 ALA A 312 REMARK 465 GLY A 313 REMARK 465 GLY A 314 REMARK 465 PHE A 315 REMARK 465 GLY A 433 REMARK 465 SER A 434 REMARK 465 SER A 435 REMARK 465 SER A 436 REMARK 465 SER A 437 REMARK 465 GLY A 438 REMARK 465 GLY A 439 REMARK 465 THR A 440 REMARK 465 CYS A 441 REMARK 465 PRO A 442 REMARK 465 SER A 443 REMARK 465 SER A 444 REMARK 465 HIS A 445 REMARK 465 GLU A 461 REMARK 465 GLY A 462 REMARK 465 SER A 463 REMARK 465 PRO A 464 REMARK 465 SER A 465 REMARK 465 ALA A 466 REMARK 465 ALA A 467 REMARK 465 ALA A 468 REMARK 465 MET B 129 REMARK 465 SER B 130 REMARK 465 GLU B 131 REMARK 465 ARG B 132 REMARK 465 THR B 133 REMARK 465 GLY B 134 REMARK 465 THR B 135 REMARK 465 GLN B 136 REMARK 465 PRO B 137 REMARK 465 LEU B 138 REMARK 465 GLY B 139 REMARK 465 VAL B 140 REMARK 465 GLN B 141 REMARK 465 LEU B 178 REMARK 465 SER B 179 REMARK 465 SER B 180 REMARK 465 GLY B 181 REMARK 465 CYS B 182 REMARK 465 GLU B 183 REMARK 465 LEU B 184 REMARK 465 PRO B 185 REMARK 465 GLU B 186 REMARK 465 SER B 187 REMARK 465 LEU B 188 REMARK 465 GLN B 189 REMARK 465 ALA B 190 REMARK 465 PRO B 191 REMARK 465 THR B 311 REMARK 465 ALA B 312 REMARK 465 GLY B 313 REMARK 465 GLY B 314 REMARK 465 PHE B 315 REMARK 465 GLY B 433 REMARK 465 SER B 434 REMARK 465 SER B 435 REMARK 465 SER B 436 REMARK 465 SER B 437 REMARK 465 GLY B 438 REMARK 465 GLY B 439 REMARK 465 THR B 440 REMARK 465 CYS B 441 REMARK 465 PRO B 442 REMARK 465 SER B 443 REMARK 465 SER B 444 REMARK 465 HIS B 445 REMARK 465 GLY B 462 REMARK 465 SER B 463 REMARK 465 PRO B 464 REMARK 465 SER B 465 REMARK 465 ALA B 466 REMARK 465 ALA B 467 REMARK 465 ALA B 468 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 193 -104.04 -109.79 REMARK 500 SER A 231 -97.72 54.12 REMARK 500 CYS A 301 69.02 -108.30 REMARK 500 PHE A 349 47.27 -91.81 REMARK 500 PRO A 382 66.19 -52.82 REMARK 500 GLN A 383 -85.61 18.49 REMARK 500 ALA A 385 -33.49 72.97 REMARK 500 PHE A 420 -16.86 -149.56 REMARK 500 HIS A 452 55.27 -144.50 REMARK 500 ARG B 193 -110.73 -112.39 REMARK 500 LEU B 209 32.06 -95.21 REMARK 500 SER B 231 83.63 -159.85 REMARK 500 LYS B 234 -1.10 -58.60 REMARK 500 CYS B 301 67.29 -105.89 REMARK 500 GLU B 309 -75.86 -61.86 REMARK 500 HIS B 418 89.09 -155.73 REMARK 500 PHE B 420 -19.02 -156.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 HIS A 407 10.70 REMARK 500 HIS B 407 10.65 REMARK 500 HIS B 407 12.70 REMARK 500 REMARK 500 REMARK: NULL DBREF 7YFK A 130 434 UNP O75469 NR1I2_HUMAN 130 434 DBREF 7YFK A 441 465 UNP Q15788 NCOA1_HUMAN 676 700 DBREF 7YFK B 130 434 UNP O75469 NR1I2_HUMAN 130 434 DBREF 7YFK B 441 465 UNP Q15788 NCOA1_HUMAN 676 700 SEQADV 7YFK MET A 129 UNP O75469 INITIATING METHIONINE SEQADV 7YFK SER A 435 UNP O75469 LINKER SEQADV 7YFK SER A 436 UNP O75469 LINKER SEQADV 7YFK SER A 437 UNP O75469 LINKER SEQADV 7YFK GLY A 438 UNP O75469 LINKER SEQADV 7YFK GLY A 439 UNP O75469 LINKER SEQADV 7YFK THR A 440 UNP O75469 LINKER SEQADV 7YFK ALA A 466 UNP Q15788 EXPRESSION TAG SEQADV 7YFK ALA A 467 UNP Q15788 EXPRESSION TAG SEQADV 7YFK ALA A 468 UNP Q15788 EXPRESSION TAG SEQADV 7YFK MET B 129 UNP O75469 INITIATING METHIONINE SEQADV 7YFK SER B 435 UNP O75469 LINKER SEQADV 7YFK SER B 436 UNP O75469 LINKER SEQADV 7YFK SER B 437 UNP O75469 LINKER SEQADV 7YFK GLY B 438 UNP O75469 LINKER SEQADV 7YFK GLY B 439 UNP O75469 LINKER SEQADV 7YFK THR B 440 UNP O75469 LINKER SEQADV 7YFK ALA B 466 UNP Q15788 EXPRESSION TAG SEQADV 7YFK ALA B 467 UNP Q15788 EXPRESSION TAG SEQADV 7YFK ALA B 468 UNP Q15788 EXPRESSION TAG SEQRES 1 A 340 MET SER GLU ARG THR GLY THR GLN PRO LEU GLY VAL GLN SEQRES 2 A 340 GLY LEU THR GLU GLU GLN ARG MET MET ILE ARG GLU LEU SEQRES 3 A 340 MET ASP ALA GLN MET LYS THR PHE ASP THR THR PHE SER SEQRES 4 A 340 HIS PHE LYS ASN PHE ARG LEU PRO GLY VAL LEU SER SER SEQRES 5 A 340 GLY CYS GLU LEU PRO GLU SER LEU GLN ALA PRO SER ARG SEQRES 6 A 340 GLU GLU ALA ALA LYS TRP SER GLN VAL ARG LYS ASP LEU SEQRES 7 A 340 CYS SER LEU LYS VAL SER LEU GLN LEU ARG GLY GLU ASP SEQRES 8 A 340 GLY SER VAL TRP ASN TYR LYS PRO PRO ALA ASP SER GLY SEQRES 9 A 340 GLY LYS GLU ILE PHE SER LEU LEU PRO HIS MET ALA ASP SEQRES 10 A 340 MET SER THR TYR MET PHE LYS GLY ILE ILE SER PHE ALA SEQRES 11 A 340 LYS VAL ILE SER TYR PHE ARG ASP LEU PRO ILE GLU ASP SEQRES 12 A 340 GLN ILE SER LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS SEQRES 13 A 340 GLN LEU ARG PHE ASN THR VAL PHE ASN ALA GLU THR GLY SEQRES 14 A 340 THR TRP GLU CYS GLY ARG LEU SER TYR CYS LEU GLU ASP SEQRES 15 A 340 THR ALA GLY GLY PHE GLN GLN LEU LEU LEU GLU PRO MET SEQRES 16 A 340 LEU LYS PHE HIS TYR MET LEU LYS LYS LEU GLN LEU HIS SEQRES 17 A 340 GLU GLU GLU TYR VAL LEU MET GLN ALA ILE SER LEU PHE SEQRES 18 A 340 SER PRO ASP ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL SEQRES 19 A 340 ASP GLN LEU GLN GLU GLN PHE ALA ILE THR LEU LYS SER SEQRES 20 A 340 TYR ILE GLU CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE SEQRES 21 A 340 LEU PHE LEU LYS ILE MET ALA MET LEU THR GLU LEU ARG SEQRES 22 A 340 SER ILE ASN ALA GLN HIS THR GLN ARG LEU LEU ARG ILE SEQRES 23 A 340 GLN ASP ILE HIS PRO PHE ALA THR PRO LEU MET GLN GLU SEQRES 24 A 340 LEU PHE GLY ILE THR GLY SER SER SER SER GLY GLY THR SEQRES 25 A 340 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 26 A 340 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER ALA SEQRES 27 A 340 ALA ALA SEQRES 1 B 340 MET SER GLU ARG THR GLY THR GLN PRO LEU GLY VAL GLN SEQRES 2 B 340 GLY LEU THR GLU GLU GLN ARG MET MET ILE ARG GLU LEU SEQRES 3 B 340 MET ASP ALA GLN MET LYS THR PHE ASP THR THR PHE SER SEQRES 4 B 340 HIS PHE LYS ASN PHE ARG LEU PRO GLY VAL LEU SER SER SEQRES 5 B 340 GLY CYS GLU LEU PRO GLU SER LEU GLN ALA PRO SER ARG SEQRES 6 B 340 GLU GLU ALA ALA LYS TRP SER GLN VAL ARG LYS ASP LEU SEQRES 7 B 340 CYS SER LEU LYS VAL SER LEU GLN LEU ARG GLY GLU ASP SEQRES 8 B 340 GLY SER VAL TRP ASN TYR LYS PRO PRO ALA ASP SER GLY SEQRES 9 B 340 GLY LYS GLU ILE PHE SER LEU LEU PRO HIS MET ALA ASP SEQRES 10 B 340 MET SER THR TYR MET PHE LYS GLY ILE ILE SER PHE ALA SEQRES 11 B 340 LYS VAL ILE SER TYR PHE ARG ASP LEU PRO ILE GLU ASP SEQRES 12 B 340 GLN ILE SER LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS SEQRES 13 B 340 GLN LEU ARG PHE ASN THR VAL PHE ASN ALA GLU THR GLY SEQRES 14 B 340 THR TRP GLU CYS GLY ARG LEU SER TYR CYS LEU GLU ASP SEQRES 15 B 340 THR ALA GLY GLY PHE GLN GLN LEU LEU LEU GLU PRO MET SEQRES 16 B 340 LEU LYS PHE HIS TYR MET LEU LYS LYS LEU GLN LEU HIS SEQRES 17 B 340 GLU GLU GLU TYR VAL LEU MET GLN ALA ILE SER LEU PHE SEQRES 18 B 340 SER PRO ASP ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL SEQRES 19 B 340 ASP GLN LEU GLN GLU GLN PHE ALA ILE THR LEU LYS SER SEQRES 20 B 340 TYR ILE GLU CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE SEQRES 21 B 340 LEU PHE LEU LYS ILE MET ALA MET LEU THR GLU LEU ARG SEQRES 22 B 340 SER ILE ASN ALA GLN HIS THR GLN ARG LEU LEU ARG ILE SEQRES 23 B 340 GLN ASP ILE HIS PRO PHE ALA THR PRO LEU MET GLN GLU SEQRES 24 B 340 LEU PHE GLY ILE THR GLY SER SER SER SER GLY GLY THR SEQRES 25 B 340 CYS PRO SER SER HIS SER SER LEU THR GLU ARG HIS LYS SEQRES 26 B 340 ILE LEU HIS ARG LEU LEU GLN GLU GLY SER PRO SER ALA SEQRES 27 B 340 ALA ALA HET G3L A 601 37 HET G3L B 601 37 HETNAM G3L NOMILIN HETSYN G3L [(1R,2R,4S,7S,8S,11R,12R,13S,18R)-7-(FURAN-3-YL)-1,8, HETSYN 2 G3L 12,17,17-PENTAMETHYL-5,15,20-TRIOXO-3,6,16- HETSYN 3 G3L TRIOXAPENTACYCLO[9.9.0.02,4.02,8.012,18]ICOSAN-13-YL] HETSYN 4 G3L ACETATE FORMUL 3 G3L 2(C28 H34 O9) FORMUL 5 HOH *187(H2 O) HELIX 1 AA1 THR A 144 PHE A 162 1 19 HELIX 2 AA2 ARG A 193 SER A 208 1 16 HELIX 3 AA3 GLY A 233 SER A 238 5 6 HELIX 4 AA4 LEU A 239 ILE A 261 1 23 HELIX 5 AA5 ILE A 261 ASP A 266 1 6 HELIX 6 AA6 PRO A 268 THR A 290 1 23 HELIX 7 AA7 GLN A 317 LEU A 320 5 4 HELIX 8 AA8 GLU A 321 LEU A 333 1 13 HELIX 9 AA9 HIS A 336 PHE A 349 1 14 HELIX 10 AB1 GLN A 358 ARG A 381 1 24 HELIX 11 AB2 PHE A 388 HIS A 418 1 31 HELIX 12 AB3 THR A 422 GLY A 430 1 9 HELIX 13 AB4 HIS A 452 LEU A 459 1 8 HELIX 14 AB5 THR B 144 PHE B 162 1 19 HELIX 15 AB6 ARG B 193 LEU B 209 1 17 HELIX 16 AB7 GLY B 233 SER B 238 5 6 HELIX 17 AB8 LEU B 239 ILE B 261 1 23 HELIX 18 AB9 ILE B 261 ASP B 266 1 6 HELIX 19 AC1 PRO B 268 VAL B 291 1 24 HELIX 20 AC2 GLN B 317 LEU B 320 5 4 HELIX 21 AC3 GLU B 321 LEU B 333 1 13 HELIX 22 AC4 HIS B 336 PHE B 349 1 14 HELIX 23 AC5 GLN B 358 ARG B 381 1 24 HELIX 24 AC6 GLN B 383 ARG B 387 5 5 HELIX 25 AC7 PHE B 388 HIS B 418 1 31 HELIX 26 AC8 THR B 422 GLY B 430 1 9 HELIX 27 AC9 THR B 449 ARG B 451 5 3 HELIX 28 AD1 HIS B 452 GLU B 461 1 10 SHEET 1 AA110 PHE A 292 ASN A 293 0 SHEET 2 AA110 THR A 298 CYS A 301 -1 O THR A 298 N ASN A 293 SHEET 3 AA110 LEU A 304 CYS A 307 -1 O LEU A 304 N CYS A 301 SHEET 4 AA110 SER A 212 ARG A 216 -1 N SER A 212 O CYS A 307 SHEET 5 AA110 VAL A 222 LYS A 226 -1 O TYR A 225 N LEU A 213 SHEET 6 AA110 VAL B 222 LYS B 226 -1 O VAL B 222 N LYS A 226 SHEET 7 AA110 VAL B 211 ARG B 216 -1 N LEU B 213 O TYR B 225 SHEET 8 AA110 LEU B 304 LEU B 308 -1 O CYS B 307 N SER B 212 SHEET 9 AA110 THR B 298 CYS B 301 -1 N TRP B 299 O TYR B 306 SHEET 10 AA110 PHE B 292 ASN B 293 -1 N ASN B 293 O THR B 298 CRYST1 84.986 90.163 106.391 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011767 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011091 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009399 0.00000